Statutory scheme to control costs of branded health service medicines

7 Aug 2018 01:06 PM

Summary

This consultation seeks views on proposed changes to the statutory scheme to control the costs of branded health medicines. 

This consultation is being held on another website.

This consultation closes at 11:59pm on 18 September 2018

Consultation description

The government is consulting on proposed changes to legislation to ensure that the overall growth of branded medicines sales made to the NHS by pharmaceutical manufacturers in the statutory medicines pricing scheme remains at a sustainable level.

The consultation seeks views on:

• the methodology for forecasting expected future branded medicines growth
• proposed changes to the method of calculating a payment percentage, based on allowed growth rates
• minor technical changes to the products in scope of payment

Documents

Proposed changes to the statutory scheme to control the costs of branded health service medicines: consultation document PDF, 239KB, 28 pages

2018 Statutory Scheme – Branded Medicines Pricing: impact assessment PDF, 1.36MB, 38 pages